BiVictriX Therapeutics shares close 7% higher after making preclinical progress
BiVictriX Therapeutics PLC (AIM:BVX, OTC:BVTXF) shares spiked 7% on Tuesday following the selection of a drug candidate from its BVX001 programme for...
Related Keywords
, Bivictrix Therapeutics ,
comparemela.com © 2020. All Rights Reserved.